Skip to main content
NVDA-2.50%AAPL+2.41%GOOGL-0.06%MSFT+0.13%AMZN+0.15%TSM-0.95%SPCX+1.70%AVGO-0.01%META-0.04%TSLA-0.55%SKHY-3.93%MU-4.37%BRK-B-0.10%LLY+0.49%JPM-0.33%AMD-2.50%WMT+0.19%V-0.04%XOM+0.09%ASMLa-1.73%JNJ-0.03%INTC-4.17%MA-0.35%0700.HK-1.94%ORCL-1.87%1398.HK+0.79%BAC-0.42%ABBV+0.54%CSCO-0.50%CVX-0.32%COST+0.07%LRCX-3.81%KO+1.02%CAT-1.08%AMAT-2.33%0005.HK-0.78%AP2d-1.62%UNH-0.55%DELL-2.90%HSBA.L-1.21%MS-0.13%PG-0.26%GE-0.12%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.01%HD-0.97%GS-0.41%0939.HK+1.66%NZDJPY-2.64%AUDJPY-1.89%CHFJPY-1.63%USDJPY-1.46%NZDCAD-1.37%GBPJPY-1.36%EURNZD+1.35%EURJPY-1.34%GBPNZD+1.29%CADJPY-1.28%NZDUSD-1.21%NZDCHF-1.05%USDNOK+0.92%EURNOK+0.87%CHFNOK+0.79%AUDNZD+0.78%USDZAR+0.72%USDSEK+0.72%EURZAR+0.67%EURSEK+0.66%AUDCAD-0.64%NOKJPY-0.64%AUDDKK-0.60%CHFSEK+0.60%GBPZAR+0.59%EURAUD+0.57%GBPAUD+0.52%AUDSGD-0.48%AUDUSD-0.44%USDMXN+0.43%USDTHB+0.42%GBPTRY+0.41%CADCHF+0.32%GBPHKD+0.32%NZDSGD-0.32%GBPMXN-0.28%EURCHF+0.28%USDPLN+0.27%AUDCHF-0.27%AUDNOK+0.27%GBPCHF+0.25%EURPLN+0.22%USDCHF+0.18%USDSGD+0.16%USDCAD-0.16%USDILS+0.16%EURUSD+0.11%SGDJPY+0.11%EURSGD+0.11%USDTRY+0.11%GBPUSD+0.10%GBPCAD-0.09%EURCZK-0.09%NZDMXN-0.08%EURHKD-0.07%USDCNH+0.06%EURCAD-0.06%USDDKK+0.05%CHFSGD+0.04%USDCOP-0.04%EURGBP+0.04%EURCNH+0.03%GBPSGD+0.02%USDHKD+0.01%PLNJPY0.00%EURDKK0.00%XPTUSD-4.75%HG1-4.48%XAGUSD-4.06%GAGUSD-4.05%UKOIL+3.70%USOIL+3.27%SUGAR+1.85%COCOA+1.35%GAUUSD-0.81%XAUUSD-0.81%COTTON+0.75%S1+0.71%BTCUSD-1.44%ETHUSD-1.28%USDTUSD-0.02%XRPUSD-2.83%SOLUSD-1.70%TRXUSDT-0.03%ZECUSDT-6.04%DOGEUSD-3.19%XMRUSDT-2.27%LINKUSD-1.44%XLMUSD-2.08%BCHUSDT-10.82%LTCUSD-1.94%UNIUSD-3.79%TONUSD+24.88%HBARUSDT-2.01%SUIUSD-3.63%TAOUSDT-5.46%AAVEUSD-3.12%DOTUSDT-3.07%ICPUSDT-1.01%ONDOUSDT-3.17%WLDUSDT-2.91%ATOMUSDT-4.49%ARBUSDT+0.77%JUPUSDT-3.39%INJUSDT-4.98%STXUSDT-3.61%FETUSDT-3.89%TIAUSDT-1.39%PYTHUSDT-0.27%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-3.23%WIFUSDT-4.89%OPUSDT-4.00%IOTAUSDT-3.93%POLUSDT-5.63%AXSUSDT-2.90%FARTCOINUSDT-3.61%EOSUSDT-0.80%DYDXUSDT-1.06%ORDIUSDT-1.36%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.50%AAPL+2.41%GOOGL-0.06%MSFT+0.13%AMZN+0.15%TSM-0.95%SPCX+1.70%AVGO-0.01%META-0.04%TSLA-0.55%SKHY-3.93%MU-4.37%BRK-B-0.10%LLY+0.49%JPM-0.33%AMD-2.50%WMT+0.19%V-0.04%XOM+0.09%ASMLa-1.73%JNJ-0.03%INTC-4.17%MA-0.35%0700.HK-1.94%ORCL-1.87%1398.HK+0.79%BAC-0.42%ABBV+0.54%CSCO-0.50%CVX-0.32%COST+0.07%LRCX-3.81%KO+1.02%CAT-1.08%AMAT-2.33%0005.HK-0.78%AP2d-1.62%UNH-0.55%DELL-2.90%HSBA.L-1.21%MS-0.13%PG-0.26%GE-0.12%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.01%HD-0.97%GS-0.41%0939.HK+1.66%NZDJPY-2.64%AUDJPY-1.89%CHFJPY-1.63%USDJPY-1.46%NZDCAD-1.37%GBPJPY-1.36%EURNZD+1.35%EURJPY-1.34%GBPNZD+1.29%CADJPY-1.28%NZDUSD-1.21%NZDCHF-1.05%USDNOK+0.92%EURNOK+0.87%CHFNOK+0.79%AUDNZD+0.78%USDZAR+0.72%USDSEK+0.72%EURZAR+0.67%EURSEK+0.66%AUDCAD-0.64%NOKJPY-0.64%AUDDKK-0.60%CHFSEK+0.60%GBPZAR+0.59%EURAUD+0.57%GBPAUD+0.52%AUDSGD-0.48%AUDUSD-0.44%USDMXN+0.43%USDTHB+0.42%GBPTRY+0.41%CADCHF+0.32%GBPHKD+0.32%NZDSGD-0.32%GBPMXN-0.28%EURCHF+0.28%USDPLN+0.27%AUDCHF-0.27%AUDNOK+0.27%GBPCHF+0.25%EURPLN+0.22%USDCHF+0.18%USDSGD+0.16%USDCAD-0.16%USDILS+0.16%EURUSD+0.11%SGDJPY+0.11%EURSGD+0.11%USDTRY+0.11%GBPUSD+0.10%GBPCAD-0.09%EURCZK-0.09%NZDMXN-0.08%EURHKD-0.07%USDCNH+0.06%EURCAD-0.06%USDDKK+0.05%CHFSGD+0.04%USDCOP-0.04%EURGBP+0.04%EURCNH+0.03%GBPSGD+0.02%USDHKD+0.01%PLNJPY0.00%EURDKK0.00%XPTUSD-4.75%HG1-4.48%XAGUSD-4.06%GAGUSD-4.05%UKOIL+3.70%USOIL+3.27%SUGAR+1.85%COCOA+1.35%GAUUSD-0.81%XAUUSD-0.81%COTTON+0.75%S1+0.71%BTCUSD-1.44%ETHUSD-1.28%USDTUSD-0.02%XRPUSD-2.83%SOLUSD-1.70%TRXUSDT-0.03%ZECUSDT-6.04%DOGEUSD-3.19%XMRUSDT-2.27%LINKUSD-1.44%XLMUSD-2.08%BCHUSDT-10.82%LTCUSD-1.94%UNIUSD-3.79%TONUSD+24.88%HBARUSDT-2.01%SUIUSD-3.63%TAOUSDT-5.46%AAVEUSD-3.12%DOTUSDT-3.07%ICPUSDT-1.01%ONDOUSDT-3.17%WLDUSDT-2.91%ATOMUSDT-4.49%ARBUSDT+0.77%JUPUSDT-3.39%INJUSDT-4.98%STXUSDT-3.61%FETUSDT-3.89%TIAUSDT-1.39%PYTHUSDT-0.27%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-3.23%WIFUSDT-4.89%OPUSDT-4.00%IOTAUSDT-3.93%POLUSDT-5.63%AXSUSDT-2.90%FARTCOINUSDT-3.61%EOSUSDT-0.80%DYDXUSDT-1.06%ORDIUSDT-1.36%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
CZ

Carl Zeiss Meditec AG (AFXd)

FRA • Healthcare

€31.26
+€0.48 (+1.6%)
Market closed

September 10, 2026 at 15:30 UTC

Open€31.02
Day Range€30.7 - €31.8
Avg. Volume (3M)225K
Market Cap€2.7B
P/E Ratio18.7
52 Week Range
€22.62€48.36

Interactive Chart

15:37:50 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned€562.7M100%
Gross Profitminus cost of goods€302.2M54%
Operating Incomeminus R&D and overhead€60.9M11%
Net Incomeminus taxes and the rest€55M10%

In plain terms: out of every €100 in revenue, Carl Zeiss Meditec AG keeps €10 as net profit.

Fundamentals & Financials

Revenue (TTM)
€2.6B
Net Income (TTM)
€116.6M
EPS (TTM)
€1.67
ROA (TTM)
0%
Current Ratio
0
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

€0.71Q2 2020
-57.9%Q3 2020€0.06

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2020
Miss -57.9%

Carl Zeiss Meditec’s third fiscal quarter of 2026 delivered a mixed read versus consensus, with EPS topping expectations while revenue trailed, as reported on August 6, 2026. Revenue rose 2.4% to about EUR 562.7 million (up from about EUR 549.6 million a year ago), but still trailed forecasts, with revenue of EUR 562.7 million against a EUR 615.3 million estimate (-8.5%). Profitability improved notably in the period, with gross margin at roughly 54% and operating margin near 11%, translating into gross profit of about EUR 302.3 million and operating income of roughly EUR 60.9 million. Net income surged 93.9% to around EUR 55.0 million, up from about EUR 28.4 million a year ago, and EPS of EUR 0.64 topped the EUR 0.39 estimate (+64.1%) while also rising 93.9% from EUR 0.33 a year ago.

View full earnings history

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG, listed on XETRA as AFX.DE, makes medical technology for eye care and surgery. In the healthcare equipment field, it sells diagnostic and therapeutic ophthalmic products and other medical instruments and supplies and, in FY2025, generated EUR 2.2 billion in revenue.

Name
Carl Zeiss Meditec AG
CEO
Andreas Pecher
Website
www.zeiss.com
Industry
Healthcare
Year Founded
1846
Employees
5,784

Today's Snapshot

AI-generated

The day ended with AFXd 1.6% higher at 31.26, while its sector was flat. Volume was about half of its usual level. TradingView analyst Andreas Pecher rated Carl Zeiss Meditec a buy.

Trading Volume

Below 10d avg (187.9K)

107.9K

vs S&P 500 Today

Outperforming Market

+2.03%

Updated: September 10, 2026 at 14:05 UTC

Technical Indicators

3 Buy2 Neutral3 Sell
AFXd trades at 31.46 and is essentially at its VWAP of 31.47, producing a mixed intraday picture while longer-term averages remain supportive and short-term averages sit above the market. Momentum is tepid with an RSI near neutral and a muted MACD while CCI and short-term momentum show weakness; ADX signals little trend strength and ATR around 1.12 points to elevated percentage volatility. OBV is negative, suggesting weak volume support even as the pivot sits slightly lower. Technical takeaway: Longer-term averages still favor a cautious buy despite short-term price pressure and weak volume.
All signals
  • EMA (5 indicators)$29.77 - $32.38
    Sell
  • RSI (14)51.13
    Neutral
  • Stochastic %K (14, 3, 3)17.23
    Buy
  • MACD Level (12, 26)0.33
    Neutral

Peers & Related Assets

BZ7A.FBumrungrad Hospital Public Company Limited
1SXP.FSCHOTT Pharma AG & Co. KGaA
FIE.DEFielmann AG
BBZA.DEBB Biotech AG
DRW3.DEDrägerwerk AG & Co. KGaA
DRW8.DEDrägerwerk AG & Co. KGaA
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.